These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 10409128)

  • 1. Characterization of receptors mediating AVP- and OT-induced glucagon release from the rat pancreas.
    Yibchok-Anun S; Cheng H; Heine PA; Hsu WH
    Am J Physiol; 1999 Jul; 277(1):E56-62. PubMed ID: 10409128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of arginine vasopressin and oxytocin on glucagon release from clonal alpha-cell line In-R1-G9: involvement of V1b receptors.
    Yibchok-anun S; Hsu WH
    Life Sci; 1998; 63(21):1871-8. PubMed ID: 9825765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of AVP and oxytocin on insulin release: involvement of V1b receptors.
    Lee B; Yang C; Chen TH; al-Azawi N; Hsu WH
    Am J Physiol; 1995 Dec; 269(6 Pt 1):E1095-100. PubMed ID: 8572202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutual regulation of vasopressin- and oxytocin-induced glucagon secretion in V1b vasopressin receptor knockout mice.
    Fujiwara Y; Hiroyama M; Sanbe A; Yamauchi J; Tsujimoto G; Tanoue A
    J Endocrinol; 2007 Feb; 192(2):361-9. PubMed ID: 17283236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxytocin-stimulated release of adrenocorticotropin from the rat pituitary is mediated by arginine vasopressin receptors of the V1b type.
    Schlosser SF; Almeida OF; Patchev VK; Yassouridis A; Elands J
    Endocrinology; 1994 Nov; 135(5):2058-63. PubMed ID: 7956927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct receptor subtypes mediate arginine vasopressin-dependent ACTH release and intracellular calcium mobilization in rat pituitary cells.
    Perdonà E; Arban R; Griffante C
    Eur J Pharmacol; 2012 Mar; 679(1-3):16-23. PubMed ID: 22285855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of oxytocin receptors, but not arginine-vasopressin V1a receptors, in the ventral tegmental area of male Syrian hamsters is essential for the reward-like properties of social interactions.
    Song Z; Borland JM; Larkin TE; O'Malley M; Albers HE
    Psychoneuroendocrinology; 2016 Dec; 74():164-172. PubMed ID: 27632574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
    Manning M; Stoev S; Chini B; Durroux T; Mouillac B; Guillon G
    Prog Brain Res; 2008; 170():473-512. PubMed ID: 18655903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of receptors mediating contraction of the rat isolated small mesenteric artery and aorta to arginine vasopressin and oxytocin.
    Stam WB; Van der Graaf PH; Saxena PR
    Br J Pharmacol; 1998 Oct; 125(4):865-73. PubMed ID: 9831926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Position 4 analogues of [deamino-Cys(1)] arginine vasopressin exhibit striking species differences for human and rat V(2)/V(1b) receptor selectivity.
    Guillon G; Pena A; Murat B; Derick S; Trueba M; Ventura MA; Szeto HH; Wo N; Stoev S; Cheng LL; Manning M
    J Pept Sci; 2006 Mar; 12(3):190-8. PubMed ID: 16130178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pharmacology of human vasopressin receptors.
    Thibonnier M; Conarty DM; Preston JA; Wilkins PL; Berti-Mattera LN; Mattera R
    Adv Exp Med Biol; 1998; 449():251-76. PubMed ID: 10026814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginine vasopressin and oxytocin effects in mouse pancreatic beta-cells. Receptors involved in stimulation of insulin release.
    Gao ZY; Henquin JC
    Diabetes; 1993 Jun; 42(6):914-21. PubMed ID: 8388343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Arg8]vasotocin excites neurones in the dorsal vagal complex in vitro: evidence for an action through novel class(es) of CNS receptors.
    Ingram CD; Tolchard S
    J Neuroendocrinol; 1994 Aug; 6(4):415-22. PubMed ID: 7987372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective blockade of oxytocin and vasopressin V(1a) receptors in anaesthetised rats: evidence that activation of oxytocin receptors rather than V(1a) receptors increases sodium excretion.
    Shirley DG; Walter MF; Keeler BD; Waters NJ; Walter SJ
    Nephron Physiol; 2011; 117(3):p21-6. PubMed ID: 21071981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxytocin pretreatment enhances arginine vasopressin-induced motor disturbances and arginine vasopressin-induced phosphoinositol hydrolysis in rat septum: a cross-sensitization phenomenon.
    Poulin P; Pittman QJ
    J Neuroendocrinol; 1993 Feb; 5(1):33-9. PubMed ID: 8387375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of YM218, a nonpeptide vasopressin V1A receptor-selective antagonist, on human vasopressin and oxytocin receptors.
    Tahara A; Tsukada J; Tomura Y; Kusayama T; Wada K; Ishii N; Taniguchi N; Suzuki T; Yatsu T; Uchida W; Shibasaki M
    Pharmacol Res; 2005 Mar; 51(3):275-81. PubMed ID: 15661579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8.
    Pena A; Murat B; Trueba M; Ventura MA; Wo NC; Szeto HH; Cheng LL; Stoev S; Guillon G; Manning M
    J Med Chem; 2007 Feb; 50(4):835-47. PubMed ID: 17300166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selectivity of d[Cha4]AVP and SSR149415 at human vasopressin and oxytocin receptors: evidence that SSR149415 is a mixed vasopressin V1b/oxytocin receptor antagonist.
    Griffante C; Green A; Curcuruto O; Haslam CP; Dickinson BA; Arban R
    Br J Pharmacol; 2005 Nov; 146(5):744-51. PubMed ID: 16158071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body temperature and cardiac changes induced by peripherally administered oxytocin, vasopressin and the non-peptide oxytocin receptor agonist WAY 267,464: a biotelemetry study in rats.
    Hicks C; Ramos L; Reekie T; Misagh GH; Narlawar R; Kassiou M; McGregor IS
    Br J Pharmacol; 2014 Jun; 171(11):2868-87. PubMed ID: 24641248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of the biological effects of neurohypophysial peptides on seminiferous tubules.
    Harris GC; Nicholson HD
    J Endocrinol; 1998 Jan; 156(1):35-42. PubMed ID: 9496231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.